Medicare

In this video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, calls out top stories in the July issue, including a cover story on chimeric antigen receptor T-cell therapy.

Proposed changes released earlier this month by CMS to the Medicare Physician Fee Schedule for 2025 should have a minimal impact on payments to nephrologists, according to a summary by the Renal Physicians Association.

The AMA adopted new policies on broader Medicare and Medicaid health care coverage during its annual House of Delegates meeting.

A bill in the U.S. House of Representatives that would slow efforts by commercial health plans from moving patients with end-stage kidney disease to Medicare now has 30 co-sponsors, according to a press release.

Physicians and medical students elected the next president of the AMA at its annual House of Delegates meeting.

DESTIN, Fla. — In this video exclusive, Robert W. Levin, MD, president of the Alliance for Transparent and Affordable Prescriptions, championed the American College of Rheumatology’s recent advocacy for an improved Medicare fee schedule.

LONG BEACH, Calif. — Getting educated on the pros and cons of Medicare Advantage may be “critically important” for patients and providers in nephrology, a speaker said, here.

Without prompt reform of Medicare reimbursement, which has failed to keep pace with the rising operation costs of rheumatology practice, rheumatologists may have no choice but to opt out of the Medicare program, noted Christina Downey, MD.

Earlier this month, members of the American Optometric Association and The Vision Council met with lawmakers on Capitol Hill to advocate for federal policy reform and promote broad access to vison care, the organizations announced.

The Medicare reimbursement rate for 10 common breast cancer-related surgical operations failed to outpace inflation over the last 20 years, according to a presentation at American Society of Breast Surgeons Annual Meeting.